Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma: New Insights in the Era of Molecular Pathology
Open Access
- 1 October 2013
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 8 (10) , 1265-1271
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatmentOncology Letters, 2012
- Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lungActa Oncologica, 2011
- Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung CancerClinical Cancer Research, 2011
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR InhibitorsScience Translational Medicine, 2011
- Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief ReportJournal of Thoracic Oncology, 2011
- Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lungCancer Science, 2007
- Results of surgery in small cell carcinoma of the lungLung Cancer, 2006
- Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancerLung Cancer, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004